A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

Abstract

Glucocorticoid treatment is usually effective for patients with IgG4-RD, and we should examine the possibility of other disorders when a patient is glucocorticoid refractory. Some patients are misdiagnosed, making central clinicopathological review of diagnosis very important in conducting clinical studies.